Markus Otto

33.3k citations
390 papers · 16.2k · 4 hit papers · h-index 70

Impact in

  • Neurology top 0.1%
    • Amyotrophic Lateral Sclerosis Research
    • Parkinson's Disease Mechanisms and Treatments
    • Neuroinflammation and Neurodegeneration Mechanisms
    • Dementia and Cognitive Impairment Research

Papers in

    • Prion Diseases and Protein Misfolding 49
    • S100 Proteins and Annexins 24
    • Amyotrophic Lateral Sclerosis Research 58
    • Parkinson's Disease Mechanisms and Treatments 44

Markus Otto

369 papers receiving 16.0k citations

Markus Otto's Hit Papers

Blood GFAP as an emerging biomarker in brain and spinal cord disorders 2022 · 472 citations
4720+2+5Years since publication4008001.2k

Peers

Markus Otto
Comparison fields: 5 of 203
  • Neurology 4.1k
  • Neurology 2.3k
  • Psychiatry and Mental health 2.7k
  • Physiology 4.5k
  • Biological Psychiatry 353
Replace Margaret A. Pericak‐Vance with:
Margaret A. Pericak‐Vance United States
Cornelia M. van Duijn Netherlands
Charlotte E. Teunissen Netherlands
Catriona McLean Australia
Jonathan L. Haines United States
Lindsay A. Farrer United States
Jeffery M. Vance United States
Ulf Andréasson Sweden
Tatiana Foroud United States
Ronald L. Hamilton United States
Markus Otto relative to Margaret A. Pericak‐Vance United States Margaret A. Pericak‐Vance's profile →
Citations per field
00.5×3.2×
Margaret A. Pericak‐Vance · 1×
Citations per year

Countries citing papers authored by Markus Otto

Since Specialization
Citations

This map shows the geographic impact of Markus Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Otto more than expected).

Fields of papers citing papers by Markus Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Otto. The network helps show where Markus Otto may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Otto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Otto Line = papers co-authored together Markus Otto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 390 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Neurofilaments as biomarkers in neurological disorders
Hit paper breakdown →
20181353
2
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
Hit paper breakdown →
2022472
3
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
Hit paper breakdown →
2019361
4 1998332
5 1997258
6 2003250
7 2003247
8 2002235
9 2018227
10 2018215
11 2002215
12 2018194
13 2003192
14 2001189
15
Virtually in this together – how web-conferencing systems enabled a new virtual togetherness during the COVID-19 crisis
Hit paper breakdown →
2020185
16 2004171
17 2015170
18 2006158
19 2008154
20 2000149

About Markus Otto

Markus Otto is a scholar working on Molecular Biology, Neurology, Physiology, Psychiatry and Mental health and Cellular and Molecular Neuroscience, having authored 390 papers that have together received 16.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (103 papers), Amyotrophic Lateral Sclerosis Research (58 papers), Prion Diseases and Protein Misfolding (49 papers), Dementia and Cognitive Impairment Research (48 papers), Parkinson's Disease Mechanisms and Treatments (44 papers), S100 Proteins and Annexins (24 papers), Multiple Sclerosis Research Studies (22 papers) and Neurogenetic and Muscular Disorders Research (17 papers). The work is most often cited by research in Neurology (4.1k citations), Neurology (2.3k citations), Psychiatry and Mental health (2.7k citations), Physiology (4.5k citations) and Biological Psychiatry (353 citations). Markus Otto has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Jens Wiltfang, Petra Steinacker, Albert C. Ludolph, Patrick Oeckl, Hayrettin Tumani, Piotr Lewczuk, Johannes Kornhuber, S. Poser, Henrik Zetterberg and Hermann Esselmann. Their work appears in journals such as Journal of Neurology, PLoS ONE, Alzheimer s & Dementia, Alzheimer s Research & Therapy and Annals of Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact